FDA Approves Remdesivir To Treat Children With COVID-19

The FDA has approved Remdesivir for children who test positive for COVID-19 and are either hospitalized or at high risk of severe illness. Pediatric patients must be at least 28 days old and weigh at least 7 pounds to receive treatment. Health experts caution that while Remdesivir is a useful tool, it should not replace COVID vaccines or booster shots.

What is the significance of the antiviral medication for pediatric patients with COVID?

What do health experts warn about the antiviral medication in relation to the COVID vaccine?